Clinical Trial Update: Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update (Valentino) evaluating panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer; current status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Vectibix (panitumumab)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN